Cellumed Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 04:35 am
Share
Cellumed Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 95.73 million compared to KRW 91.91 million a year ago. Net income was KRW 654.39 million compared to net loss of KRW 297.72 million a year ago. Basic earnings per share from continuing operations was KRW 18 compared to basic loss per share from continuing operations of KRW 9 a year ago. Diluted earnings per share from continuing operations was KRW 14 compared to diluted loss per share from continuing operations of KRW 9 a year ago. Basic earnings per share was KRW 17 compared to basic loss per share of KRW 7 a year ago. Diluted earnings per share was KRW 13 compared to diluted loss per share of KRW 7 a year ago.
For the six months, sales was KRW 197.25 million compared to KRW 152.18 million a year ago. Net income was KRW 2,871.48 million compared to net loss of KRW 215.59 million a year ago. Basic earnings per share from continuing operations was KRW 74 compared to basic loss per share from continuing operations of KRW 9 a year ago. Diluted earnings per share from continuing operations was KRW 69 compared to diluted loss per share from continuing operations of KRW 9 a year ago. Basic earnings per share was KRW 72 compared to basic loss per share of KRW 6 a year ago. Diluted earnings per share was KRW 67 compared to diluted loss per share of KRW 6 a year ago.
CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Companyâs products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.
CELLUMED CO.,LTD. 
